Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Primary Care/Hospitalist

RSS  

Articles

  • Meta-analysis Finds Little Evidence of Increased Side Effects in Women Using Phytoestrogens

    A meta-analysis was conducted of the incidence of side effects reported in randomized controlled trials of women taking phytoestrogens for the treatment of menopausal symptoms. Except for gastrointestinal side effects, women taking phytoestrogens were not at higher risk of side effects.
  • Busy Signals: Cell Phone Use and Cancer

    Concerns over cell phones use and subsequent development of cancer, especially brain tumors, have occasionally dominated the news and helped create an entire business sector devoted to hands-free devices.
  • Give RA Patients the 'Hook' - TwHF

    A standardized extract of Tripterygium wilfordii Hook F root was compared with sulfasalazine therapy in subjects with active rheumatoid arthritis. After a 24-week intervention, those taking the botanical remedy experienced significantly greater progress both clinically and in laboratory assessments when compared with the sulfasalazine group, with improvements occurring rapidly. The findings are hampered somewhat by a significant dropout rate in both study groups.
  • Can Mindfulness Save Primary Care?

    This single-group cohort before-and-after study of an intensive educational program for primary care physicians focusing on mindful communication and self-awareness demonstrated improvements in physician well-being and attitudes toward patient- centered care.
  • Pralatrexate Injection (Folotyn™)

    The FDA has approved the first treatment for relapsed or refractory peripheral T-cell lymphoma. Pralatrexate, an inhibitor of dihydrofolate reductase, was granted accelerated approval by the FDA. It will be marketed by Allos Therapeutics as Folotyn™.
  • ECG Review: How Many Early/Blocked Findings?

    The ECG shown above was obtained from a 72-year-old woman as a baseline. How would you interpret her ECG? How many blocked and early findings can you identify?
  • Clinical Briefs By Louis Kuritzky, MD

    The antiplatelet effect of clopidogrel is dependent upon its conversion and activation through the 2C19 pathway of the P450 system. Blockade of this pathway occurs because of genetics, in persons who do not have sufficiently active 2C19, and pharmacotherapies that specifically block 2C19. Proton pump inhibitors (PPIs), particularly omeprazole, are recognized to be 2C19 inhibitors. Is there reason for concern?
  • Dementia Drugs Make the Ticker Sicker

    Cholinesterase inhibitors place patients at risk for syncope, bradycardia, permanent pacemaker insertion, and hip fracture.
  • Vitamin D Deficiency Linked to Increased Mortality in Older Adults

    Low levels of serum 25-hydroxyvitamin D [25(OH)D] in non-institutionalized older adults were associated with future increased mortality from all causes and from cardiovascular disease.
  • Do Physicians Believe in Shared Decision Making for Prostate Cancer Screening?

    Although health care providers have a major influence on their patients when they decide to undergo screening for prostate cancer, shared decision making often does not occur despite recommendations.